Back to Rankings

LPCN

LipocineA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
LPCN vs peer average
95/100
LPCN vs. peer average (A vs. F)
Grade spread
C 1 · F 7
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

ALLR is the first available peer comparator.

Loose same-sector, similar-market-cap biotech screen peer; useful mainly for comparing financing and event-driven risk, not as a direct product analogue.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerALLRAllarity Therapeutics
LPCN
Lipocine
ALLR
Allarity Therapeutics
Grade
A
F
Momentum
100
21
Value
57
41
Sentiment
41
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs ALLR

LPCN / ALLR
Grade Position
Above peers
LPCN vs. peer average (A vs. F)
95/100
Momentum
100
LPCN
Value
57
LPCN
Sentiment
41
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs LPCN
1
ALLR
ALLR
F
20/100
+4
2
HOWL
HOWL
F
20/100
+4
3
NEUP
NEUP
F
20/100
+4
4
QNCX
QNCX
F
20/100
+4
5
RKTO
RKTO
F
20/100
+4
ALLR is the first peer returned for this comparison set.